Similar articles

• Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification.

  Ikeda T, Sakurada H, Sakabe K, Sakata T, Takami M, Tezuka N, Nakae T, Noro M, Enjoji Y, Tejima T, Sugi K, Yamaguchi T. Ikeda T, et al. J Am Coll Cardiol. 2001 May;37(6):1628-34. doi: 10.1016/s0735-1097(01)01197-4. J Am Coll Cardiol. 2001. PMID: 11345376
• Use of signal-averaged electrocardiography for predicting inducible sustained monomorphic ventricular tachycardia in patients with bundle branch block with and without a history of syncope.

  Englund A, Rosenqvist M, Bergfeldt L. Englund A, et al. Am Heart J. 1995 Sep;130(3 Pt 1):481-8. doi: 10.1016/0002-8703(95)90355-0. Am Heart J. 1995. PMID: 7661064
• Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child.

  Probst V, Evain S, Gournay V, Marie A, Schott JJ, Boisseau P, LE Marec H. Probst V, et al. J Cardiovasc Electrophysiol. 2006 Jan;17(1):97-100. doi: 10.1111/j.1540-8167.2005.00329.x. J Cardiovasc Electrophysiol. 2006. PMID: 16426410
• Brugada syndrome: from cell to bedside.

  Antzelevitch C, Brugada P, Brugada J, Brugada R. Antzelevitch C, et al. Curr Probl Cardiol. 2005 Jan;30(1):9-54. doi: 10.1016/j.cpcardiol.2004.04.005. Curr Probl Cardiol. 2005. PMID: 15627121 Free PMC article. Review.
• Proposed diagnostic criteria for the Brugada syndrome.

  Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA; Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Wilde AA, et al. Eur Heart J. 2002 Nov;23(21):1648-54. doi: 10.1053/euhj.2002.3382. Eur Heart J. 2002. PMID: 12448445 Review. No abstract available.